Christopher D.�M. Fletcher
0000-0002-8053-9537
Publication & Citation Trends
Most Cited Works
Publications
843 total
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
Cited by 947
OpenAlex
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial PDF
Cited by 2,058
OpenAlex
Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
Cited by 1,074
OpenAlex
Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <i>KIT</i> PDF
Cited by 1,001
OpenAlex
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
Cited by 2,587
OpenAlex
The evolving classification of soft tissue tumours: an update based on the new WHO classification
Cited by 913
OpenAlex
Research Topics
Sarcoma Diagnosis and Treatment
(447)
Soft tissue tumor case studies
(170)
Vascular Tumors and Angiosarcomas
(149)
Gastrointestinal Tumor Research and Treatment
(91)
Cardiac tumors and thrombi
(88)
Frequent Co-Authors
Affiliations
Boston University
Universitat Autònoma de Barcelona
University of Maryland, Baltimore
Atrium Health Wake Forest Baptist
Brigham and Women's Hospital